<p>Daxor Corporation（纳斯达克代码：DXR - 获取免费报告）在周三的午盘交易中下跌了 1.2%。该股票最低交易价格为 12.60 美元，最后交易价格为 12.79 美元。在交易中共交易了 888 股，较平均交易量 12,613 股下降了 93%。该股票之前的收盘价为 12.94 美元。</p>
<h2>华尔街分析师预测增长</h2>
<p>另外，Weiss Ratings 在 10 月 8 日的研究报告中重申了对 Daxor 股票的 “持有（c-）” 评级。一位股票研究分析师给予该股票买入评级，另一位则给予持有评级。根据 MarketBeat 的数据，该股票的平均评级为 “适度买入”，平均目标价格为 25.00 美元。</p>
<p><strong>获取我们对 DXR 的最新股票分析</strong></p>
<h2>Daxor 价格表现</h2>
<p>该公司的 50 日移动平均价格为 12.78 美元，200 日移动平均价格为 10.60 美元。</p>
<h2>Daxor 的机构交易</h2>
<p>一家机构投资者最近在 Daxor 股票中建立了新头寸。Osaic Holdings Inc.在第二季度收购了 Daxor Corporation（纳斯达克代码：DXR - 免费报告）的新头寸，根据其最近向证券交易委员会提交的 13F 表格。该公司收购了 8,750 股公司股票，价值约 86,000 美元。Osaic Holdings Inc.在最近的报告期末拥有 Daxor 约 0.18% 的股份。机构投资者和对冲基金持有该公司 1.34% 的股票。</p>
<h2>关于 Daxor</h2>
<p>（获取免费报告）</p>
<p>Daxor Corporation 是一家医疗设备公司，提供专注于血容量测试的血容量测量技术。该公司开发并销售 BVA-100 血容量分析仪，这是一种诊断性血液测试，旨在提供安全、准确、客观的血容量状态和成分的量化，与患者特定的标准相比，适用于广泛的医疗和外科条件。</p>
<h2>精选文章</h2>
<ul>
<li>五只我们更看好的股票比 Daxor 更好</li>
<li>何时出售股票以获利或亏损</li>
<li>onsemi 对其自身股票下注 60 亿美元</li>
<li>股票分析师评级和加拿大分析师评级</li>
<li>HIMS 经历了过山车般的旅程。投资者应该上车吗？</li>
<li>英国市场假期是什么？如何投资和交易</li>
<li>以这三只复苏冠军强势结束年末</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Daxor 吗？</h2>
<p>在考虑 Daxor 之前，你会想听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Daxor 不在名单上。</p>
<p>虽然 Daxor 目前在分析师中有适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

<p>Daxor Corporation（纳斯达克代码：DXR）在周三的午盘交易中股价下跌了 1.2%，最低交易价格为 12.60 美元。交易量显著低于平均水平。分析师对该股票给予了适度买入评级，目标价格为 25.00 美元。机构投资者持有该公司 1.34% 的股份。Daxor 专注于血容量测量技术。尽管近期股价下跌，分析师建议考虑其他股票以寻求更好的投资机会</p>

<p>Daxor Corporation (NASDAQ:DXR - Get Free Report) traded down 1.2% during mid-day trading on Wednesday . The stock traded as low as $12.60 and last traded at $12.79. 888 shares were traded during trading, a decline of 93% from the average session volume of 12,613 shares. The stock had previously closed at $12.94.</p>
<div class="lb-trans"><p>Daxor Corporation（纳斯达克代码：DXR - 获取免费报告）在周三的午盘交易中下跌了 1.2%。该股票最低交易价格为 12.60 美元，最后交易价格为 12.79 美元。在交易中共交易了 888 股，较平均交易量 12,613 股下降了 93%。该股票之前的收盘价为 12.94 美元。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><p>Separately, Weiss Ratings restated a &#34;hold (c-)&#34; rating on shares of Daxor in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat, the stock has an average rating of &#34;Moderate Buy&#34; and an average target price of $25.00.</p>
<div class="lb-trans"><p>另外，Weiss Ratings 在 10 月 8 日的研究报告中重申了对 Daxor 股票的 “持有（c-）” 评级。一位股票研究分析师给予该股票买入评级，另一位则给予持有评级。根据 MarketBeat 的数据，该股票的平均评级为 “适度买入”，平均目标价格为 25.00 美元。</p>
</div><p><strong>Get Our Latest Stock Analysis on DXR</strong></p>
<div class="lb-trans"><p><strong>获取我们对 DXR 的最新股票分析</strong></p>
</div><h2>Daxor Price Performance</h2>
<div class="lb-trans"><h2>Daxor 价格表现</h2>
</div><p>The business has a 50-day moving average price of $12.78 and a two-hundred day moving average price of $10.60.</p>
<div class="lb-trans"><p>该公司的 50 日移动平均价格为 12.78 美元，200 日移动平均价格为 10.60 美元。</p>
</div><h2>Institutional Trading of Daxor</h2>
<div class="lb-trans"><h2>Daxor 的机构交易</h2>
</div><p>An institutional investor recently bought a new position in Daxor stock. Osaic Holdings Inc. acquired a new position in shares of Daxor Corporation (NASDAQ:DXR - Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 8,750 shares of the company's stock, valued at approximately $86,000. Osaic Holdings Inc. owned approximately 0.18% of Daxor at the end of the most recent reporting period. Institutional investors and hedge funds own 1.34% of the company's stock.</p>
<div class="lb-trans"><p>一家机构投资者最近在 Daxor 股票中建立了新头寸。Osaic Holdings Inc.在第二季度收购了 Daxor Corporation（纳斯达克代码：DXR - 免费报告）的新头寸，根据其最近向证券交易委员会提交的 13F 表格。该公司收购了 8,750 股公司股票，价值约 86,000 美元。Osaic Holdings Inc.在最近的报告期末拥有 Daxor 约 0.18% 的股份。机构投资者和对冲基金持有该公司 1.34% 的股票。</p>
</div><h2>About Daxor</h2>
<div class="lb-trans"><h2>关于 Daxor</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions.</p>
<div class="lb-trans"><p>Daxor Corporation 是一家医疗设备公司，提供专注于血容量测试的血容量测量技术。该公司开发并销售 BVA-100 血容量分析仪，这是一种诊断性血液测试，旨在提供安全、准确、客观的血容量状态和成分的量化，与患者特定的标准相比，适用于广泛的医疗和外科条件。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than Daxor</li>
<li>When to Sell a Stock for Profit or Loss</li>
<li>onsemi Places a $6 Billion Bet on Its Own Stock</li>
<li>Stock Analyst Ratings and Canadian Analyst Ratings</li>
<li>HIMS Has Been a Roller Coaster Ride. Should Investors Hop On?</li>
<li>What Are the U.K. Market Holidays? How to Invest and Trade</li>
<li>End the Year Strong With These 3 Comeback Champions</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票比 Daxor 更好</li>
<li>何时出售股票以获利或亏损</li>
<li>onsemi 对其自身股票下注 60 亿美元</li>
<li>股票分析师评级和加拿大分析师评级</li>
<li>HIMS 经历了过山车般的旅程。投资者应该上车吗？</li>
<li>英国市场假期是什么？如何投资和交易</li>
<li>以这三只复苏冠军强势结束年末</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Daxor Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Daxor 吗？</h2>
</div><p>Before you consider Daxor, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Daxor 之前，你会想听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Daxor wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Daxor 不在名单上。</p>
</div><p>While Daxor currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Daxor 目前在分析师中有适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Daxor (NASDAQ:DXR) 股价下跌 1.2% - 你是否应该卖出？